SABATINI BRENT (SVP, Chief Accounting Officer) sold 11.1% of their position (7.71K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $70.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/24/2026ACC: 0001628280-26-020823
Officer· SVP, Chief Accounting Officer
Since Feb 2026
-7.71K
Net shares
Net seller
$70.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
7.71K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−7.71K
Price / share
$9.12
Trade value
$70.32K
% of position
11.1%
3/23/2026
69.61K→61.90K
Total
Net shares
−7.71K
Net value
-$70.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/23/2026 | S · Sale | −7.71K | $9.12 | $70.32K | 11.1% | 69.61K | 61.90K |
| Total | −7.71K | -$70.32K | ||||||
Derivative Transactions0
No derivative transactions reported